Study Aims
The primary goal of this study was to assess safety of the OIT protocol
by analyzing the percentage of patients experiencing adverse effects
during the up-dosing phase, documented at each appointment. Symptoms
severity was assessed using the validated ordinal food allergy severity
scale (O-FASS-5)21, with grade 1 reactions categorized
as mild, grades 2-3 reactions as moderate, and grades 4- 5 as severe.
Furthermore, we conducted additional analyses to assess the successful
completion of the maintenance phase and to explore changes in
immunological parameters.